TAYLOR SANDLIN: Open Payments
NPI 1114678240 · WATKINSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 35 payments from 16 companies in 2025. Trend: 2023 $1,416 · 2024 $1,161 · 2025 $950
Food & beverage: $950
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $303 |
| Galderma Laboratories, L.P. | 3 | $154 |
| UCB, Inc. | 3 | $117 |
| ABBVIE INC. | 3 | $68 |
| Organon LLC | 3 | $49 |
| LEO Pharma Inc. | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $35 |
| Lilly USA, LLC | 1 | $23 |
| Amgen Inc. | 1 | $23 |
Products named: DUPIXENT, NEMLUVIO, Bimzelx, SKYRIZI, ADBRY, VTAMA, TALTZ, Otezla.
Industry payments across GA — which companies pay providers there.
